Literature DB >> 32735192

Making the Case for Syringe Services Programs.

Jerome M Adams.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32735192      PMCID： PMC7407057          DOI： 10.1177/0033354920936233

Source DB:  PubMed          Journal:  Public Health Rep        ISSN： 0033-3549            Impact factor:   2.792


× No keyword cloud information.
  14 in total

1.  Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors.

Authors:  H Hagan; J P McGough; H Thiede; S Hopkins; J Duchin; E R Alexander
Journal:  J Subst Abuse Treat       Date:  2000-10

2.  Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario.

Authors:  Pamela N Leece; Shaun Hopkins; Chantel Marshall; Aaron Orkin; Margaret A Gassanov; Rita M Shahin
Journal:  Can J Public Health       Date:  2013-04-18

3.  Changes in Reported Injection Behaviors Following the Public Health Response to an HIV Outbreak Among People Who Inject Drugs: Indiana, 2016.

Authors:  Sharoda Dasgupta; Dita Broz; Mary Tanner; Monita Patel; Brandon Halleck; Philip J Peters; Paul J Weidle; Julie O'Donnell; Joseph Amlung; Cameron McAlister; Erika Chapman; Ayriane Bailey; Janet Burnett; Joan Duwve
Journal:  AIDS Behav       Date:  2019-12

4.  Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014.

Authors:  Jon E Zibbell; Alice K Asher; Rajiv C Patel; Ben Kupronis; Kashif Iqbal; John W Ward; Deborah Holtzman
Journal:  Am J Public Health       Date:  2017-12-21       Impact factor: 9.308

5.  Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy.

Authors:  Natasha K Martin; Matthew Hickman; Sharon J Hutchinson; David J Goldberg; Peter Vickerman
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

Review 6.  Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis.

Authors:  Esther J Aspinall; Dhanya Nambiar; David J Goldberg; Matthew Hickman; Amanda Weir; Eva Van Velzen; Norah Palmateer; Joseph S Doyle; Margaret E Hellard; Sharon J Hutchinson
Journal:  Int J Epidemiol       Date:  2013-12-27       Impact factor: 7.196

7.  Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population.

Authors:  Harinder S Chahal; Elliot A Marseille; Jeffrey A Tice; Steve D Pearson; Daniel A Ollendorf; Rena K Fox; James G Kahn
Journal:  JAMA Intern Med       Date:  2016-01       Impact factor: 44.409

8.  Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.

Authors:  Cora L Bernard; Douglas K Owens; Jeremy D Goldhaber-Fiebert; Margaret L Brandeau
Journal:  PLoS Med       Date:  2017-05-24       Impact factor: 11.613

9.  Access to Syringe Services Programs - Kentucky, North Carolina, and West Virginia, 2013-2017.

Authors:  Danae Bixler; Greg Corby-Lee; Scott Proescholdbell; Tina Ramirez; Michael E Kilkenny; Matt LaRocco; Robert Childs; Michael R Brumage; Angela D Settle; Eyasu H Teshale; Alice Asher
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-05-11       Impact factor: 17.586

10.  Using Interrupted Time Series Analysis to Measure the Impact of Legalized Syringe Exchange on HIV Diagnoses in Baltimore and Philadelphia.

Authors:  Monica S Ruiz; Allison OʼRourke; Sean T Allen; David R Holtgrave; David Metzger; Jose Benitez; Kathleen A Brady; C Patrick Chaulk; Leana S Wen
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12-01       Impact factor: 3.731
View more
  3 in total

1.  Policy and Public Health : Reducing the Burden of Infectious Diseases.

Authors:  Deron C Burton; Scott Burris; Jonathan H Mermin; David W Purcell; Sara C Zeigler; Lara Bull-Otterson; Hazel D Dean
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

2.  Public Health Reports: 2020 in Review.

Authors:  Andrey Kuzmichev; Nnedi Onyejiuwa; Patricia L Jones; Hazel D Dean
Journal:  Public Health Rep       Date:  2021-05       Impact factor: 2.792

3.  Latent Classes of Polysubstance Use and Associations with HIV Risk and Structural Vulnerabilities among Cisgender Women Who Engage in Street-Based Transactional Sex in Baltimore City.

Authors:  Sam Wilson Beckham; Jennifer L Glick; Kristin E Schneider; Sean T Allen; Lillian Shipp; Rebecca Hamilton White; Ju Nyeong Park; Susan G Sherman
Journal:  Int J Environ Res Public Health       Date:  2022-03-22       Impact factor: 3.390
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.